TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event

Insider Trading

Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.

All Recent Buys Recent Sells
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).
Ticker Insider Title Date Transaction Price ($) Shares Value ($) SEC Form 4
MSFT Coleman Amy EVP, Chief Human Resources Off 09/15/2026 Steuer-Abgabe 505.41 36 18,195 Form 4
LITE Wupen Yuen PRESIDENT, GLOBAL BUS. UNITS 09/15/2026 Verkauf 841.51 500 420,755 Form 4
LCLN Weber Mary Rose Chief Operating Officer 09/15/2026 Zuteilung — 141 — Form 4
LCLN Oleniczak John William Director 09/15/2026 Zuteilung — 8 — Form 4
LCLN Malchow Eric Dennis President & Global Head of M&A 09/15/2026 Zuteilung — 634 — Form 4
LCLN Brown Robert Todd Chief Executive Officer 09/15/2026 Zuteilung — 986 — Form 4
LCLN Marvin Kristin Marie General Counsel 09/15/2026 Zuteilung — 71 — Form 4
LCLN Heidloff Theodore J. Chief Financial Officer 09/15/2026 Zuteilung — 71 — Form 4
LMB Horowitz Joshua Director 09/15/2026 Kauf 51.25 662 33,928 Form 4
LMB Horowitz Joshua Director 09/15/2026 Kauf 50.61 3,346 169,331 Form 4
LMB Horowitz Joshua Director 09/15/2026 Kauf 50.66 212 10,740 Form 4
INV Grieco William J. Chief Executive Officer 09/15/2026 J — 8,103 — Form 4
INBX Manhard Kimberly Director 09/15/2026 Verkauf 105.05 500 52,525 Form 4
HTFL Verghese Vikram Chief Financial Officer 09/15/2026 Verkauf 50.01 668 33,408 Form 4
HFWA Rivera Frederick B Director 09/15/2026 Verkauf 28.57 1,300 37,135 Form 4
GWRE Mullen John P President 09/15/2026 Optionsausübung — 75,211 — Form 4
GWRE Cooper Jeffrey Elliott Chief Financial Officer 09/15/2026 Optionsausübung — 37,826 — Form 4
GWRE Rosenbaum Michael George Chief Executive Officer 09/15/2026 Optionsausübung — 123,074 — Form 4
GWRE King James Winston Chief Admin Officer, Gen Couns 09/15/2026 Optionsausübung — 19,701 — Form 4
GWRE Peterson David Franklin Chief Accounting Officer 09/15/2026 Optionsausübung — 4,351 — Form 4
GDRX Chan Thomas (TC) Chief Accounting Officer 09/15/2026 Steuer-Abgabe 3.56 1,069 3,806 Form 4
GDRX Chan Thomas (TC) Chief Accounting Officer 09/15/2026 Optionsausübung — 2,101 — Form 4
GDRX Fengler Justin See Remarks 09/15/2026 Steuer-Abgabe 3.56 330 1,175 Form 4
GDRX Fengler Justin See Remarks 09/15/2026 Optionsausübung — 752 — Form 4
GDRX Fengler Justin See Remarks 09/15/2026 Steuer-Abgabe 3.56 1,024 3,645 Form 4
GDRX Fengler Justin See Remarks 09/15/2026 Optionsausübung — 2,335 — Form 4
GLOO Thrivent Financial For Lutherans 10% Owner 09/15/2026 Verkauf 3.34 5,000 16,715 Form 4
GAM Stark Eugene S VP Administration 09/15/2026 Kauf 24.00 5,000 120,000 Form 4
FBLG Khoja Hamid Chief Scientific Officer 09/15/2026 Zuteilung 1.68 298,508 500,001 Form 4
CURB Fennerty Conor EVP, CFO & Treasurer 09/15/2026 Steuer-Abgabe 29.08 2,472 71,886 Form 4
CURB Cattonar John M EVP & Chief Investment Officer 09/15/2026 Steuer-Abgabe 29.08 2,472 71,886 Form 4
NET Seifert Thomas J Chief Financial Officer 09/15/2026 Steuer-Abgabe 327.23 2,944 963,365 Form 4
CELH DeSantis Damon Director 09/15/2026 Kauf 27.95 16,000 447,200 Form 4
CYTK Landry Robert E Director 09/15/2026 Verkauf 72.13 1,000 72,130 Form 4
CYTK Blum Robert I President & CEO 09/15/2026 Verkauf 69.33 97,926 6,789,210 Form 4
CSPI Nerges Joseph R 10% Owner 09/15/2026 Kauf 7.96 472 3,757 Form 4
CSPI Nerges Joseph R 10% Owner 09/15/2026 Kauf 7.90 28 221 Form 4
CCOI Kilmer Henry W VP OF NETWORK STRATEGY 09/15/2026 Verkauf 9.21 2,400 22,104 Form 4
CLOV Soares Karen Chief Legal Officer 09/15/2026 Verkauf 4.78 6,846 32,724 Form 4
CLOV Reynoso Jamie L. CEO, Medicare Advantage 09/15/2026 Verkauf 4.78 9,273 44,325 Form 4
CZFS Landy R Joseph Director 09/15/2026 Zuteilung — 70 — Form 4
CZFS DePaola Rinaldo A Director 09/15/2026 Zuteilung — 70 — Form 4
CZFS Hilfiger Janie M Director 09/15/2026 Zuteilung — 70 — Form 4
CZFS Painter John P II Director 09/15/2026 Zuteilung — 70 — Form 4
CZFS Behm John D Director 09/15/2026 Zuteilung — 70 — Form 4
CZFS Bower Joseph B Jr Director 09/15/2026 Zuteilung — 70 — Form 4
CZFS Freeman Thomas E. Director 09/15/2026 Zuteilung — 70 — Form 4
CZFS Kunes Christopher W Director 09/15/2026 Zuteilung — 70 — Form 4
CZFS Chappell Robert W Director 09/15/2026 Zuteilung — 70 — Form 4
CZFS Osborne Terry B Director 09/15/2026 Zuteilung — 70 — Form 4
CZFS Jones Mickey L Director 09/15/2026 Zuteilung — 70 — Form 4
CZFS Graham Roger C Jr Director 09/15/2026 Zuteilung — 70 — Form 4
XYZ Eisen Anthony Mathew Director 09/15/2026 Verkauf 79.31 6,000 475,860 Form 4
ARTV Aslan Fred Chief Executive Officer 09/15/2026 Zuteilung — 110,000 — Form 4
AMBQ Esaka Fumihide Chief Executive Officer 09/15/2026 Verkauf 61.00 100 6,100 Form 4
AMBQ Esaka Fumihide Chief Executive Officer 09/15/2026 Verkauf 60.55 9,615 582,171 Form 4
AMBQ Esaka Fumihide Chief Executive Officer 09/15/2026 Verkauf 59.56 3,785 225,444 Form 4
AMBQ Esaka Fumihide Chief Executive Officer 09/15/2026 Optionsausübung 8.12 13,500 109,620 Form 4
AVT Jacobson Kenneth A Chief Financial Officer 09/15/2026 Abgabe 92.75 6,844 634,781 Form 4
AIZ Demmings Keith President & CEO 09/15/2026 Schenkung — 3,500 — Form 4

A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).

Was this page helpful to you?